108 related articles for article (PubMed ID: 21918510)
41. High maintenance dosage of clopidogrel is associated with a reduced risk of stent thrombosis in clopidogrel-resistant patients.
Tavassoli N; Voisin S; Carrie D; Lapeyre-Mestre M; Galinier M; Montastruc JL; Pathak A
Am J Cardiovasc Drugs; 2010; 10(1):29-35. PubMed ID: 20104932
[TBL] [Abstract][Full Text] [Related]
42. Combined impact of matrix metalloproteinase-3 and paraoxonase 1 55/192 gene variants on coronary artery disease in Turkish patients.
Ozkök E; Aydin M; Babalik E; Ozbek Z; Ince N; Kara I
Med Sci Monit; 2008 Oct; 14(10):CR536-42. PubMed ID: 18830194
[TBL] [Abstract][Full Text] [Related]
43. Clopidogrel in addition to aspirin reduces one-year major adverse cardiac and cerebrovascular events in unselected patients with non-ST segment elevation myocardial infarction.
Zeymer U; Gitt AK; Zahn R; Jünger C; Bauer T; Köth O; Heer T; Wienbergen H; Gottwik M; Senges J
Acute Card Care; 2008; 10(1):43-8. PubMed ID: 17924233
[TBL] [Abstract][Full Text] [Related]
44. Long-term outcomes by clopidogrel duration and stent type in a diabetic population with de novo coronary artery lesions.
Brar SS; Kim J; Brar SK; Zadegan R; Ree M; Liu IL; Mansukhani P; Aharonian V; Hyett R; Shen AY
J Am Coll Cardiol; 2008 Jun; 51(23):2220-7. PubMed ID: 18534267
[TBL] [Abstract][Full Text] [Related]
45. Association between
Biswas M; Kali SK; Sarker AK; Sukasem C
Expert Opin Drug Saf; 2023; 22(9):807-817. PubMed ID: 37148265
[TBL] [Abstract][Full Text] [Related]
46. Paraoxonase 1 (PON1) gene variants are not associated with clopidogrel response.
Lewis JP; Fisch AS; Ryan K; O'Connell JR; Gibson Q; Mitchell BD; Shen H; Tanner K; Horenstein RB; Pakzy R; Tantry US; Bliden KP; Gurbel PA; Shuldiner AR
Clin Pharmacol Ther; 2011 Oct; 90(4):568-74. PubMed ID: 21881565
[TBL] [Abstract][Full Text] [Related]
47. Association of PON1 genotype and haplotype with susceptibility to coronary artery disease and clinical outcomes in dual antiplatelet-treated Han Chinese patients.
Kang YH; Lao HY; Wu H; Lai WH; Li XX; Yu XY; Chen JY; Zhong SL
Eur J Clin Pharmacol; 2013 Aug; 69(8):1511-9. PubMed ID: 23608957
[TBL] [Abstract][Full Text] [Related]
48. Paraoxonase-1 is not a major determinant of stent thrombosis in a Taiwanese population.
Chen DY; Wang CY; Wen MS; Lee TH; Chu Y; Hsieh MJ; Chang SH; Lee CH; Wang JL; Chen CC; Lu LS; Lee MT; Yeh SJ; Lin FC; Hsieh IC
PLoS One; 2012; 7(6):e39178. PubMed ID: 22723959
[TBL] [Abstract][Full Text] [Related]
49. Cytochrome p450 gene variants, race, and mortality among clopidogrel-treated patients after acute myocardial infarction.
Cresci S; Depta JP; Lenzini PA; Li AY; Lanfear DE; Province MA; Spertus JA; Bach RG
Circ Cardiovasc Genet; 2014 Jun; 7(3):277-86. PubMed ID: 24762860
[TBL] [Abstract][Full Text] [Related]
50. Influence of the paraoxonase-1 Q192R genetic variant on clopidogrel responsiveness and recurrent cardiovascular events: a systematic review and meta-analysis.
Reny JL; Combescure C; Daali Y; Fontana P;
J Thromb Haemost; 2012 Jul; 10(7):1242-51. PubMed ID: 22520065
[TBL] [Abstract][Full Text] [Related]
51. PON1 Q192R and clopidogrel: a case of the winner's curse or inadequate replication?
Talameh JA; McLeod HL
Clin Pharmacol Ther; 2011 Dec; 90(6):771-4. PubMed ID: 22089342
[TBL] [Abstract][Full Text] [Related]
52. Clinical outcomes associated with proton pump inhibitor use among clopidogrel-treated patients within CYP2C19 genotype groups following acute myocardial infarction.
Depta JP; Lenzini PA; Lanfear DE; Wang TY; Spertus JA; Bach RG; Cresci S
Pharmacogenomics J; 2015 Feb; 15(1):20-5. PubMed ID: 25001880
[TBL] [Abstract][Full Text] [Related]
53. Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk.
Bhattacharyya T; Nicholls SJ; Topol EJ; Zhang R; Yang X; Schmitt D; Fu X; Shao M; Brennan DM; Ellis SG; Brennan ML; Allayee H; Lusis AJ; Hazen SL
JAMA; 2008 Mar; 299(11):1265-76. PubMed ID: 18349088
[TBL] [Abstract][Full Text] [Related]
54. Unveiling the mysteries of clopidogrel metabolism and efficacy.
Bonello L; Bonello N; Grosdidier C; Camoin-Jau L
Clin Pharmacol Ther; 2011 Dec; 90(6):774-6. PubMed ID: 22089343
[TBL] [Abstract][Full Text] [Related]
55. Genetic and Nongenetic Factors Affecting Clopidogrel Response in the Egyptian Population.
Khalil BM; Shahin MH; Solayman MH; Langaee T; Schaalan MF; Gong Y; Hammad LN; Al-Mesallamy HO; Hamdy NM; El-Hammady WA; Johnson JA
Clin Transl Sci; 2016 Feb; 9(1):23-8. PubMed ID: 26757134
[TBL] [Abstract][Full Text] [Related]
56. Paraoxonase2 C311S polymorphism and low levels of HDL contribute to a higher mortality risk after acute myocardial infarction in elderly patients.
Marchegiani F; Spazzafumo L; Provinciali M; Cardelli M; Olivieri F; Franceschi C; Lattanzio F; Antonicelli R
Mol Genet Metab; 2009 Nov; 98(3):314-8. PubMed ID: 19540141
[TBL] [Abstract][Full Text] [Related]
57. Paraoxonase-1 is a major determinant of clopidogrel efficacy.
Bouman HJ; Schömig E; van Werkum JW; Velder J; Hackeng CM; Hirschhäuser C; Waldmann C; Schmalz HG; ten Berg JM; Taubert D
Nat Med; 2011 Jan; 17(1):110-6. PubMed ID: 21170047
[TBL] [Abstract][Full Text] [Related]
58. PON1 polymorphism, diabetes mellitus, obesity, and risk of myocardial infarction: Modifying effect of diabetes mellitus and obesity on the association between PON1 polymorphism and myocardial infarction.
Li J; Wang X; Huo Y; Niu T; Chen C; Zhu G; Huang Y; Chen D; Xu X
Genet Med; 2005 Jan; 7(1):58-63. PubMed ID: 15654230
[TBL] [Abstract][Full Text] [Related]
59. The influence of renal function on the association of rs854560 polymorphism of paraoxonase 1 gene with long-term prognosis in patients after myocardial infarction.
Szpakowicz A; Pepinski W; Waszkiewicz E; Maciorkowska D; Skawronska M; Niemcunowicz-Janica A; Dobrzycki S; Musial WJ; Kaminski KA
Heart Vessels; 2016 Jan; 31(1):15-22. PubMed ID: 25155309
[TBL] [Abstract][Full Text] [Related]
60. The association of the PON1 Q192R polymorphism with complications and outcomes of pregnancy: findings from the British Women's Heart and Health cohort study.
Lawlor DA; Gaunt TR; Hinks LJ; Davey Smith G; Timpson N; Day IN; Ebrahim S
Paediatr Perinat Epidemiol; 2006 May; 20(3):244-50. PubMed ID: 16629699
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
